Emendo biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.
We leverage our expertise in protein engineering to bring innovative and disruptive protein tools to resolve the bottleneck of the field.
Location: Israel, Center District, Rehovot
Member count: 51-200
Total raised: $61M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Takeda Ven... | takeda.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 15.01.2020 | - | $61M | - | citybizlis... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 15.01.2020 | Emendo rai... | Emendo Biotherapeutics has rai... | Biotech | - | fiercebiot... |
| 15.01.2020 | Emendo Bio... | NEW YORK--(BUSINESS WIRE)--Eme... | - | - | citybizlis... |
| 15.01.2020 | Emendo rai... | Emendo Biotherapeutics has rai... | Biotech | - | fiercebiot... |